| Literature DB >> 309948 |
H Jones, M W Fordice, R B Greenwald, J Hannah, A Jacobs, W V Ruyle, G L Walford, T Y Shen.
Abstract
We have made a series of 4- and 5-aryl- and 4- and 5-heteroarylsalicylic acid derivatives with the objective of reducing gastric irritation and increasing potency. Here we describe a series of 4- and 5-heterocyclic salicylic acids and their antiinflammatory-analgesic potencies measured in comparison to aspirin. An improvement of the therapeutic index over aspirin of 100 was achieved; however, the heterocyclic salicylic acids lacked antipyretic activity. Some physicochemical parameters which may bear on the antiinflammatory activity of these compounds are discussed.Entities:
Mesh:
Substances:
Year: 1978 PMID: 309948 DOI: 10.1021/jm00209a002
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446